Jasmine A Luzum

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Venues

Pharmacogenomics

Clinical pharmacology and therapeutics

NPJ genomic medicine

Future cardiology

University of Michigan

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan Jul 01 2016

United States

Assistant Professor

Education History

University of North Carolina at Chapel Hill

United States

PHD

Publications

Julio D Duarte, Cameron D Thomas, And Craig R Lee, Rachel Huddart, José A G Agúndez, Jordan F Baye, Andrea Gaedigk, Teri E Klein, David E Lanfear, Andrew A Monte, Mohamed Nagy, Matthias Schwab, C Michael Stein, Chakradhara Rao Satyanarayana Uppugunduri, Ron H N van Schaik, Roseann S Donnelly, Kelly E Caudle, Jasmine A Luzum
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical pharmacology and therapeutics (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Julio D Duarte, Cameron D Thomas, And Craig R Lee, Rachel Huddart, José A G Agúndez, Jordan F Baye, Andrea Gaedigk, Teri E Klein, David E Lanfear, Andrew A Monte, Mohamed Nagy, Matthias Schwab, C Michael Stein, Chakradhara Rao Satyanarayana Uppugunduri, Ron H N van Schaik, Roseann S Donnelly, Kelly E Caudle, Jasmine A Luzum
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical pharmacology and therapeutics (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics (2024)
Snezana Kusljic, Jasmine A Luzum
It is time for educators to act: pharmacogenomics education and its implementation into clinical practice. Pharmacogenomics (2024)
Jasmine A Luzum, Alessandra M Campos-Staffico, Jia Li, Ruicong She, Hongsheng Gui, Edward L Peterson, Bin Liu, Hani N Sabbah, Mark P Donahue, William E Kraus, L Keoki Williams, David E Lanfear
Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction. Genes 14 (11) (2023)
Akinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, D Max Smith, Matteo Castrichini, Kristine R Crews, William A Murphy, Nam H K Nguyen, Yimei Huang, Christelle Lteif, Kevin A Friede, Kelan Tantisira, Folefac Aminkeng, Deepak Voora, Larisa H Cavallari, Michelle Whirl-Carrillo, Julio D Duarte, Jasmine A Luzum, null null
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers. Clinical pharmacology and therapeutics (2023)
David E Lanfear, Jasmine A Luzum, Ruicong She, Jia Li, Hani N Sabbah, Nicole Zeld, Bin Liu, Edward Peterson, L Keoki Williams
Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank. Circulation. Genomic and precision medicine (2023)
Hongsheng Gui, Wai Hong Wilson Tang, Stephan Francke, Jia Li, Ruicong She, Peter Bazeley, Naveen L Pereira, Kirkwood Adams, Jasmine A Luzum, Thomas M Connolly, Adrian F Hernandez, Candace D McNaughton, L Keoki Williams, David E Lanfear
Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial. Circulation. Heart failure 16 (9) (2023)
Wilson Chen, Heather M Ochs-Balcom, Changxing Ma, Paul J Isackson, Georgirene D Vladutiu, Jasmine A Luzum
Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms. Future cardiology 18 (6) (2022)
Ana I Lopez-Medina, Choudhary Anwar A Chahal, Jasmine A Luzum
The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants. Pharmacogenomics 23 (9) (2022)
Joseph D English, Shuo Tian, Zhong Wang, Jasmine A Luzum
Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case-Control Studies. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Jasmine A Luzum, Natasha J Petry, Annette K Taylor, Sara L Van Driest, Henry M Dunnenberger, Larisa H Cavallari
Moving Pharmacogenetics Into Practice: It's All About the Evidence! Clinical pharmacology and therapeutics 110 (3) (2021)
Derek W Linskey, David C Linskey, Howard L McLeod, Jasmine A Luzum
The need to shift pharmacogenetic research from candidate gene to genome-wide association studies. Pharmacogenomics 22 (17) (2021)
Tyler Shugg, Amy L Pasternak, Bianca London, Jasmine A Luzum
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources. NPJ genomic medicine 5 (2020)
Takuto Takahashi, Jasmine A Luzum, Melanie R Nicol, Pamala A Jacobson
Pharmacogenomics of COVID-19 therapies. NPJ genomic medicine 5 (2020)
Tyler Shugg, Amy L Pasternak, Bianca London, Jasmine A Luzum
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources. NPJ genomic medicine 5 (1) (2020)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Jasmine A Luzum
QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights. Journal of cardiovascular electrophysiology 31 (10) (2020)
Jasmine A Luzum, Christopher Ting, Edward L Peterson, Hongsheng Gui, Tyler Shugg, L Keoki Williams, Liang Li, Wolfgang Sadee, Danxin Wang, David E Lanfear
Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure. Cardiovascular drugs and therapy 33 (6) (2020)
Jasmine A Luzum, Joseph D English, Umair S Ahmad, Jessie W Sun, Benjamin D Canan, Wolfgang Sadee, Joseph P Kitzmiller, Philip F Binkley
Association of Genetic Polymorphisms in the Beta-1 Adrenergic Receptor with Recovery of Left Ventricular Ejection Fraction in Patients with Heart Failure. Journal of cardiovascular translational research 12 (4) (2019)

Jasmine A Luzum.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jasmine A Luzum